Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Post by NorCalTommyon Jun 16, 2021 5:40pm
598 Views
Post# 33399455

Theralase current status

Theralase current statusSorry i haven't been following the message board for awhile but love the TLT story, recently had a big position and hopefully buying back soon... I came across your post Eoganacht... and i found myself wondering if the Theralase story is still as exciting and ready to pop, with the obstacles you mention below regarding Photosensitizer uptake... is this considered a new discovery, did they not know this all along? Is TLT running into obstacles and conditions that they had not completely considered and factored into their therapy, or am i just making too much out of this excerpt below? Is it going to take a host of different applications/procedures by TLT instead of a much more defined and 2x per year frequency treatement that seemed uber elegant and very simple..... now it appears that there are lots of variables....  but again i am not close to expert on these therapies... so i would be very interested in your take (Fred, Cancer Slayer, EOG, and the 'extremely knowledgeable crowd') on how you believe TLT is currently doing?  are they 'on plan' or in the middle of 'course corrections/mods/revs' to make the PDT treatment more effective??

Thanks immensely in advance!!

EOGANACHT's Post Excerpt:


It’s acknowledged that the inter- and intra-patient variability of the tissue optical properties and the photosensitizer uptake remains a major obstacle to fully exploit the dual selectivity of PDT, resulting even with the application of precision PDT treatment planning in highly variable treatment outcomes. Enabling personalized PDT treatment planning requires the ability to quantify or predict the locally variable tissue optical properties, photosensitizer accumulation and oxygen availability
<< Previous
Bullboard Posts
Next >>